Rosen Law Firm Encourages Larimar Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – LRMR

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Larimar Therapeutics, Inc. due to allegations of materially misleading business information issued by the company [1]. Summary by Relevant Sections - Company Investigation: The investigation focuses on Larimar Therapeutics, Inc. (NASDAQ: LRMR) and the potential impact of misleading information on its shareholders [1]. - Shareholder Rights: Shareholders who purchased Larimar Therapeutics securities may be entitled to compensation without incurring out-of-pocket fees or costs [1].